The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoshimura, T.
Right arrow Articles by Yoshida, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoshimura, T.
Right arrow Articles by Yoshida, H.
The Journal of Immunology, 2006, 177: 5377-5385.
Copyright © 2006 by The American Association of Immunologists, Inc.

Two-Sided Roles of IL-27: Induction of Th1 Differentiation on Naive CD4+ T Cells versus Suppression of Proinflammatory Cytokine Production Including IL-23-Induced IL-17 on Activated CD4+ T Cells Partially Through STAT3-Dependent Mechanism1

Takeru Yoshimura*,{dagger}, Atsunobu Takeda*,{dagger}, Shinjiro Hamano{ddagger}, Yoshiyuki Miyazaki*,§, Ichiko Kinjyo*, Tatsuro Ishibashi{dagger}, Akihiko Yoshimura* and Hiroki Yoshida2,*,§

* Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation and Department of {dagger} Ophthalmology and {ddagger} Department of Parasitology, Graduate School of Medical Sciences; Kyushu University, Fukuoka, Japan; § Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Honcho Kawaguchi, Japan; and Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan

Recent lines of evidence have demonstrated that IL-27, a newly identified IL-12-related cytokine, has two apparently conflicting roles in immune responses: one as an initiator of Th1 responses and the other as an attenuator of inflammatory cytokine production. Although the IL-27-mediated Th1 initiation mechanism has been elucidated, little is known about the molecular basis for the suppression of cytokine production. In the present study, we demonstrated that IL-27 suppressed the production of various proinflammatory cytokines by fully activated CD4+ T cells while it had no effect on the cytokine production by CD4+ T cells at early phases of activation. IL-27 also suppressed IL-17 production by activated CD4+ T cells, thereby counteracting IL-23, another IL-12-related cytokine with proinflammatory effects. In fully activated CD4+ T cells, STAT3 was preferentially activated by IL-27 stimulation, whereas both STAT1 and 3 were activated by IL-27 in early activated CD4+ T cells. Lack of STAT3 in fully activated cells impaired the suppressive effects of IL-27. These data indicated that the preferential activation of STAT3 in fully activated CD4+ T cells plays an important role in the cytokine suppression by IL-27/WSX-1.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This study was supported in part by grants from the Ministry of Education, Science, Technology, Sports and Culture of Japan (to H.Y. and A.Y.), from Terumo Life Science Foundation (to S.H.), from Japan Research Foundation for Clinical Pharmacology (to H.Y.), from the Sumitomo Foundation, Grant for Basic Science Research Projects (to H.Y.), and from the Naito Foundation (to H.Y.). This work was also supported by the president’s expenditure (research project expenditure) of Saga University (to H.Y.).

2 Address correspondence and reprint requests to Dr. Hiroki Yoshida, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Nabeshima, Saga, 849-8501, Japan. E-mail address: yoshidah{at}med.saga-u.ac.jp

3 Abbreviations used in this paper: SOCS, suppressor of cytokine signaling; LMNC, liver mononuclear cell; pY, anti-phosphotyrosine.




This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
L. K. STAMP, A. EASSON, L. PETTERSSON, J. HIGHTON, and P. A. HESSIAN
Monocyte Derived Interleukin (IL)-23 Is an Important Determinant of Synovial IL-17A Expression in Rheumatoid Arthritis
J Rheumatol, November 1, 2009; 36(11): 2403 - 2408.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. S. Ramgolam, Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese
IFN-{beta} Inhibits Human Th17 Cell Differentiation
J. Immunol., October 15, 2009; 183(8): 5418 - 5427.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. El-behi, B. Ciric, S. Yu, G.-X. Zhang, D. C. Fitzgerald, and A. Rostami
Differential Effect of IL-27 on Developing versus Committed Th17 Cells
J. Immunol., October 15, 2009; 183(8): 4957 - 4967.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Greenwell-Wild, N. Vazquez, W. Jin, Z. Rangel, P. J. Munson, and S. M. Wahl
Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon
Blood, August 27, 2009; 114(9): 1864 - 1874.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. E. Troy, C. Zaph, Y. Du, B. C. Taylor, K. J. Guild, C. A. Hunter, C. J. M. Saris, and D. Artis
IL-27 Regulates Homeostasis of the Intestinal CD4+ Effector T Cell Pool and Limits Intestinal Inflammation in a Murine Model of Colitis
J. Immunol., August 1, 2009; 183(3): 2037 - 2044.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Salcedo, J. A. Hixon, J. K. Stauffer, R. Jalah, A. D. Brooks, T. Khan, R.-M. Dai, L. Scheetz, E. Lincoln, T. C. Back, et al.
Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
J. Immunol., April 1, 2009; 182(7): 4328 - 4338.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Matsui, T. Kishida, H. Nakano, K. Yoshimoto, M. Shin-Ya, T. Shimada, S. Nakai, J. Imanishi, T. Yoshimoto, Y. Hisa, et al.
Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
Cancer Res., March 15, 2009; 69(6): 2523 - 2530.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
N Sugiyama, H Nakashima, T Yoshimura, A Sadanaga, S Shimizu, K Masutani, T Igawa, M Akahoshi, K Miyake, A Takeda, et al.
Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor {alpha} (WSX-1)
Ann Rheum Dis, October 1, 2008; 67(10): 1461 - 1467.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
W Niedbala, B Cai, X Wei, A Patakas, B P Leung, I B McInnes, and F Y Liew
Interleukin 27 attenuates collagen-induced arthritis
Ann Rheum Dis, October 1, 2008; 67(10): 1474 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. V. Villarino, D. Artis, J. S. Bezbradica, O. Miller, C. J. M. Saris, S. Joyce, and C. A. Hunter
IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD
Int. Immunol., June 1, 2008; 20(6): 739 - 752.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. Paunovic, H. P. Carroll, K. Vandenbroeck, and M. Gadina
Signalling, inflammation and arthritis: Crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity
Rheumatology, June 1, 2008; 47(6): 771 - 776.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. D. Kalliolias and L. B. Ivashkiv
IL-27 Activates Human Monocytes via STAT1 and Suppresses IL-10 Production but the Inflammatory Functions of IL-27 Are Abrogated by TLRs and p38
J. Immunol., May 1, 2008; 180(9): 6325 - 6333.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Tanaka, K. Ichiyama, M. Hashimoto, H. Yoshida, T. Takimoto, G. Takaesu, T. Torisu, T. Hanada, H. Yasukawa, S. Fukuyama, et al.
Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-{gamma} on STAT3 and Smads
J. Immunol., March 15, 2008; 180(6): 3746 - 3756.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Batten, N. M. Kljavin, J. Li, M. J. Walter, F. J. de Sauvage, and N. Ghilardi
Cutting Edge: IL-27 Is a Potent Inducer of IL-10 but Not FoxP3 in Murine T Cells
J. Immunol., March 1, 2008; 180(5): 2752 - 2756.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Owaki, M. Asakawa, N. Morishima, I. Mizoguchi, F. Fukai, K. Takeda, J. Mizuguchi, and T. Yoshimoto
STAT3 Is Indispensable to IL-27-Mediated Cell Proliferation but Not to IL-27-Induced Th1 Differentiation and Suppression of Proinflammatory Cytokine Production
J. Immunol., March 1, 2008; 180(5): 2903 - 2911.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Huber, V. Steinwald, A. Guralnik, A. Brustle, P. Kleemann, C. Rosenplanter, T. Decker, and M. Lohoff
IL-27 inhibits the development of regulatory T cells via STAT3
Int. Immunol., February 1, 2008; 20(2): 223 - 234.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Wang, Y. Miyazaki, Y. Shinozaki, and H. Yoshida
Augmentation of Antigen-Presenting and Th1-Promoting Functions of Dendritic Cells by WSX-1(IL-27R) Deficiency
J. Immunol., November 15, 2007; 179(10): 6421 - 6428.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Pirhonen, J. Siren, I. Julkunen, and S. Matikainen
IFN-{alpha} regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages
J. Leukoc. Biol., November 1, 2007; 82(5): 1185 - 1192.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Brender, G. M. Tannahill, B. J. Jenkins, J. Fletcher, R. Columbus, C. J. M. Saris, M. Ernst, N. A. Nicola, D. J. Hilton, W. S. Alexander, et al.
Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27
Blood, October 1, 2007; 110(7): 2528 - 2536.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Fitzgerald, B. Ciric, T. Touil, H. Harle, J. Grammatikopolou, J. D. Sarma, B. Gran, G.-X. Zhang, and A. Rostami
Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis
J. Immunol., September 1, 2007; 179(5): 3268 - 3275.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Liu, X. Guan, and X. Ma
Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-{gamma}-mediated pathways
J. Exp. Med., January 22, 2007; 204(1): 141 - 152.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.